SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-044925
Filing Date
2009-03-04
Accepted
2009-03-04 16:44:59
Documents
3
Period of Report
2009-02-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17473
2 PRESS RELEASE dex991.htm EX-99.1 7998
3 GRAPHIC g67781ex99_1pg1.jpg GRAPHIC 8600
  Complete submission text file 0001193125-09-044925.txt   39311
Mailing Address 134 COOLIDGE AVE WATERTOWN MA 02472
Business Address 134 COOLIDGE AVE WATERTOWN MA 02472 617-926-1551
PANACOS PHARMACEUTICALS, INC. (Filer) CIK: 0001040017 (see all company filings)

IRS No.: 113238476 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24241 | Film No.: 09656022
SIC: 2836 Biological Products, (No Diagnostic Substances)